Cell and cell-derivative-based therapy for liver diseases: current approaches and future promises

References

• Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70:151–171.
   PubMed Web of Science ®Google Scholar
• Zahmatkesh E, Othman A, Braun B, et al. In vitro modeling of liver fibrosis in 3D microtissues using scalable micropatterning system. Arch Toxicol. 2022;96:1799–1813.
   PubMed Web of Science ®Google Scholar
• Kriegermeier A, Green R. Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies. Front Med. 2020;7:149.
   Web of Science ®Google Scholar
• Zhou GP, Jiang YZ, Sun LY, et al. Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2020;11:1–19.
   PubMed Web of Science ®Google Scholar
• Dwyer BJ, Macmillan MT, Brennan PN, et al. Cell therapy for advanced liver diseases: repair or rebuild. J Hepatol. 2021;74:185–199.
   PubMed Web of Science ®Google Scholar
• Zahmatkesh E, Vosough M. A quick update from the past to current status of human pluripotent stem cell-derived hepatocyte culture systems. Mod Med Lab J. 2019;2:110–112.
   Google Scholar
• Yang X, Meng Y, Han Z, et al. Mesenchymal stem cell therapy for liver disease: full of chances and challenges. Cell Biosci. 2020;10:1–18.
   PubMed Web of Science ®Google Scholar
• Li Y, Lu L, Cai X. Liver regeneration and cell transplantation for end-stage liver disease. Biomolecules. 2021;11:1907.
   PubMed Web of Science ®Google Scholar
• Vosough M, Moslem M, Pournasr B, et al. Cell-based therapeutics for liver disorders. Br Med Bull. 2011;100:157–172.
   PubMed Web of Science ®Google Scholar
• Lee SM, Lee SD, Wang SZ, et al. Effect of mesenchymal stem cell in liver regeneration and clinical applications. Hepatoma Res. 2021;9:1598.
   Google Scholar
• Nicolas CT, Kaiser RA, Hickey RD, et al. Ex vivo cell therapy by ectopic hepatocyte transplantation treats the porcine tyrosinemia model of acute liver failure. Mol Ther - Methods Clin Dev. 2020;18:738–750.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Que W, Zhu P, et al. The role of diverse liver cells in liver transplantation tolerance. Front Immunol. 2020;11:1–16.
   PubMed Web of Science ®Google Scholar
• Chu DT, Nguyen TT, Tien NLB, et al. Recent progress of stem cell therapy in cancer treatment: molecular mechanisms and potential applications. Cells. 2020;9:1–19.
   Web of Science ®Google Scholar
• Moradi S, Mahdizadeh H, Šarić T, et al. Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations. Stem Cell Res Ther. 2019;10:1–13.
   PubMed Web of Science ®Google Scholar
• Desgres M, Menasché P. Clinical translation of pluripotent stem cell therapies: challenges and considerations. Cell Stem Cell. 2019;25:594–606.
   PubMed Web of Science ®Google Scholar
• Anderson TN, Zarrinpar A. Hepatocyte transplantation: past efforts, current technology, and future expansion of therapeutic potential. J Sur G Res. 2019;226:48–55.
   Web of Science ®Google Scholar
• Groth CG, Arborgh B, Bjo¨rke´n C, et al. Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation. 1997;4:262–266.
   PubMed Web of Science ®Google Scholar
• Guerra Ruiz AR, Crespo J, López Martínez RM, et al. Measurement and clinical usefulness of bilirubin in liver disease. Adv Lab Med. 2021;2:352–361.
   Google Scholar
• Yoshida Y, Tokusashi Y, Lee GH, et al. Intrahepatic transplantation of normal hepatocytes prevents Wilson’s disease in Long-Evans cinnamon rats. Gastroenterology. 1996;111:1654–1660.
   PubMed Web of Science ®Google Scholar
• De Vree JML, Ottenhoff R, Bosma PJ, et al. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology. 2000;119:1720–1730.
   PubMed Web of Science ®Google Scholar
• Mito M, Kusano M. Hepatocyte transplantation in man. Cell Transplant. 1993;2:65–74.
   Web of Science ®Google Scholar
• Ambrosino G, Varotto S, Strom SC, et al. Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant. 2005;14:151–157.
   PubMed Web of Science ®Google Scholar
• Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis. 2006;29:431–435.
   PubMed Web of Science ®Google Scholar
• Fox IJ, Chowdhury JR, Kaufman SSGT, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998;338:1422–1426.
   PubMed Web of Science ®Google Scholar
• Bilir BM, Guinette D, Karrer F, et al. Hepatocyte transplantation in acute liver failure. Liver Transplant. 2000;6:32–40.
   PubMed Web of Science ®Google Scholar
• Habibullah C, Syed I, Qamar AT-UZ. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation. 1994;58:951–952.
   PubMed Web of Science ®Google Scholar
• Stéphenne X, Najimi M, Smets F, et al. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant. 2005;5:2058–2061.
   PubMed Web of Science ®Google Scholar
• Stéphenne X, Najimi M, Sibille C, et al. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology. 2006;130:1317–1323.
   PubMed Web of Science ®Google Scholar
• Muraca M, Gerunda G, Neri D, et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet. 2002;359:317–318.
   PubMed Web of Science ®Google Scholar
• Lee KW, Lee JH, Sung WS, et al. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant. 2007;16:629–637.
   PubMed Web of Science ®Google Scholar
• Dhawan A, Mitry RR, Hughes RD, et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation. 2004;78:1812–1814.
   PubMed Web of Science ®Google Scholar
• Sokal EM, Smets F, Bourgois A, et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation. 2003;76:735–738.
   PubMed Web of Science ®Google Scholar
• Strom SC, Roy Chowdhury J, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis. 1999;19:39–48.
   PubMed Web of Science ®Google Scholar
• Kozarsky K, Iii BJC, Stein EA, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med. 1995;1:1148–1154.
   PubMed Web of Science ®Google Scholar
• Liu J, Yuan Z, Wang Q. Pluripotent stem cell-derived strategies to treat acute liver failure: current status and future directions. J Clin Transl Hepatol. 2022;10:692–699.
   PubMed Web of Science ®Google Scholar
• Li X, Wang Y, Yang H, et al. Liver and hepatocyte transplantation: what can pigs contribute? Front Immunol. 2022;12:1–7.
   Web of Science ®Google Scholar
• Iansante V, Mitry RR, Filippi C, et al. Human hepatocyte transplantation for liver disease: current status and future perspectives. Nat Publ Gr. 2017;83:232–240.
   Google Scholar
• Kitto LJ, Henderson NC. Hepatic stellate cell regulation of liver regeneration and repair. Hepatol Commun. 2021;5:358–370.
   PubMed Web of Science ®Google Scholar
• Tolosa L, Pareja-Ibars E, Teresa Donato M, et al. Neonatal livers: a source for the isolation of good-performing hepatocytes for cell transplantation. Cell Transplant. 2014;23:1229–1242.
   PubMed Web of Science ®Google Scholar
• Lee CA, Dhawan A, Iansante V, et al. Cryopreserved neonatal hepatocytes may be a source for transplantation: evaluation of functionality toward clinical use. Liver Transplant. 2018;24:394–406.
   PubMed Web of Science ®Google Scholar
• Kozubenko N, Turnovcova K, Kapcalova M, et al. Analysis of in vitro and in vivo characteristics of human embryonic stem cell-derived neural precursors. Cell Transplant. 2010;19:471–486.
   PubMed Web of Science ®Google Scholar
• Giancotti A, Monti M, Nevi L, et al. Functions and the emerging role of the foetal liver into regenerative medicine. Cells. 2019;9:1–19.
   PubMedGoogle Scholar
• Bruno S, Herrera Sanchez MB, Chiabotto G, et al. Human liver stem cells: a liver-derived mesenchymal stromal cell-like population with pro-regenerative properties. Front Cell Dev Biol. 2021;9:1–14.
   Web of Science ®Google Scholar
• Wang B, Wu L, Chen J, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;26:94.
   Google Scholar
• Denner J. Porcine endogenous retroviruses and xenotransplantation, 2021. Viruses. 2021;13:2156.
   PubMed Web of Science ®Google Scholar
• Grompe M. Fah knockout animals as models for therapeutic liver repopulation. Adv Exp Med Biol. 2017;959:215–230.
   PubMed Web of Science ®Google Scholar
• Larson EL, Joo DJ, Nelson ED, et al. Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production. Stem Cell Reports. 2021;16:2577–2588.
   PubMed Web of Science ®Google Scholar
• Lee JY, Hong SH. Hematopoietic stem cells and their roles in tissue regeneration. Int J Stem Cells. 2020;13:1–12.
   PubMed Web of Science ®Google Scholar
• Lewis K, Yoshimoto M, Takebe T. Fetal liver hematopoiesis: from development to delivery. Stem Cell Res Ther. 2021;12:1–8.
   PubMed Web of Science ®Google Scholar
• Soares-da-Silva F, Peixoto M, Cumano A, et al. Crosstalk between the hepatic and hematopoietic systems during embryonic development. Front Cell Dev Biol. 2020;8:1–20.
   PubMed Web of Science ®Google Scholar
• Filip S, Mokrý J, Vávrová J, et al. The peripheral chimerism of bone marrow-derived stem cells after transplantation: regeneration of gastrointestinal tissues in lethally irradiated mice. J Cell Mol Med. 2014;18:832–843.
   PubMed Web of Science ®Google Scholar
• Hofling AA, Vogler C, Creer MH, et al. Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease. Blood. 2003;101:2054–2063.
   PubMed Web of Science ®Google Scholar
• Ma F, Wada M, Yoshino H, et al. Development of human lymphohematopoietic stem and progenitor cells defined by expression of CD34 and CD81. Blood. 2001;97:3755–3762.
   PubMed Web of Science ®Google Scholar
• Salama H, Zekri ARN, Bahnassy AA, et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol. 2010;16:5297–5305.
   PubMed Web of Science ®Google Scholar
• Mohamadnejad M, Vosough M, Moossavi S, et al. Intraportal infusion of bone marrow mononuclear or CD133 + cells in patients with decompensated cirrhosis: a double-blind randomized controlled trial. Stem Cells Transl Med. 2016;5:87–94.
   PubMed Web of Science ®Google Scholar
• Vosough M, Moossavi S, Mardpour S, et al. Repeated intraportal injection of mesenchymal stem cells in combination with pioglitazone in patients with compensated cirrhosis: a clinical report of two cases. Arch Iran Med. 2016;19:131–136.
   PubMed Web of Science ®Google Scholar
• Wang J, Sun M, Liu W, et al. Stem cell-based therapies for liver diseases: an overview and update. Tissue Eng Regen Med. 2019;16:107–118.
   PubMed Web of Science ®Google Scholar
• Zekri ARN, Salama H, Medhat E, et al. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency. Stem Cell Res Ther. 2015;6:1–14.
   PubMed Web of Science ®Google Scholar
• Thomas JA, Pope C, Wojtacha D, et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology. 2011;53:2003–2015.
   PubMed Web of Science ®Google Scholar
• Goichberg P. Current understanding of the pathways involved in adult stem and progenitor cell migration for tissue homeostasis and repair. Stem Cell Rev Rep. 2016;12:421–437.
   PubMed Web of Science ®Google Scholar
• Nikeghbalian S, Pournasr B, Aghdami N, et al. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med. 2011;14:12–17.
   PubMed Web of Science ®Google Scholar
• Esmaeilzadeh A, Ommati H, Kooshyar MM, et al. Autologous bone marrow stem cell transplantation in liver cirrhosis after correcting nutritional anomalies, a controlled clinical study. Cell J. 2019;21:268–273.
   PubMed Web of Science ®Google Scholar
• Kantarcioʇlu M, Demirci H, Avcu F, et al. Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis. Turkish J Gastroenterol. 2015;26:244–250.
   PubMed Web of Science ®Google Scholar
• Kharaziha P, Hellström PM, Noorinayer B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;21:1199–1205.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Discher DE, Péault BM, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regen Med. 2019;4:22.
   PubMed Web of Science ®Google Scholar
• Almeida-Porada G, Atala AJ, Porada CD. Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery. Mol Ther - Methods Clin Dev. 2020;16:204–224.
   PubMed Web of Science ®Google Scholar
• Wang J, Cen P, Chen J, et al. Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure. Stem Cell Res Ther. 2017;8:4–9.
   PubMed Web of Science ®Google Scholar
• Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: a review of the literature and future directions. Regen Ther. 2020;14:136–153.
   PubMed Web of Science ®Google Scholar
• Kangari P, Talaei-Khozani T, Razeghian-Jahromi I, et al. Mesenchymal stem cells: amazing remedies for bone and cartilage defects. Stem Cell Res Ther. 2020;11:1–21.
   PubMed Web of Science ®Google Scholar
• Ding Y, Luo Q, Que H, et al. Mesenchymal stem cell-derived exosomes: a promising therapeutic agent for the treatment of liver diseases. Int J Mol Sci. 2022;23:10972.
   PubMedGoogle Scholar
• Shahrbaf MA, Nouri M, Zarrabi M, et al. Extraembryonic mesenchymal stromal/stem cells in liver diseases: a critical revision of promising advanced therapy medicinal products. Cells. 2022;11:1072.
   PubMed Web of Science ®Google Scholar
• Wu X, Jiang J, Gu Z, et al. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Stem Cell Res Ther. 2020;11:1–16.
   PubMed Web of Science ®Google Scholar
• Weiss ARR, Dahlke MH. Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol. 2019;10:1–10.
   PubMed Web of Science ®Google Scholar
• Bocca C, Protopapa F, Foglia B, et al. Hepatic myofibroblasts: a heterogeneous and redox-modulated cell population in liver fibrogenesis. Antioxidants. 2022;11:1278.
   Web of Science ®Google Scholar
• Nazarie SR, Gharbia S, Hermenean A, et al. Regenerative potential of mesenchymal stem cells’ (MSCs) secretome for liver fibrosis therapies. Int J Mol Sci. 2021;22:13292.
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen BChen L jun, et al. Current Status and Future Prospects of Mesenchymal Stem Cell Therapy for Liver Fibrosis J Zhejiang Univ Sci B. 2016;17:831–841.
   PubMed Web of Science ®Google Scholar
• Lee KC, Lin HC, Huang YH, et al. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease. J Hepatol. 2015;63:1405–1412.
   PubMed Web of Science ®Google Scholar
• Jo H, Brito S, Kwak BM, et al. Applications of mesenchymal stem cells in skin regeneration and rejuvenation. Int J Mol Sci. 2021;22:1–18.
   Web of Science ®Google Scholar
• Ji W, Hou B, Lin W, et al. 3D Bioprinting a human iPSC-derived MSC-loaded scaffold for repair of the uterine endometrium. Acta Biomater. 2020;116:268–284.
   PubMed Web of Science ®Google Scholar
• Kagia A, Tzetis M, Kanavakis E, et al. Therapeutic effects of mesenchymal stem cells derived from bone marrow, umbilical cord blood, and pluripotent stem cells in a mouse model of chemically induced inflammatory bowel disease. Inflammation. 2019;42:1730–1740.
   PubMed Web of Science ®Google Scholar
• Kim IG, Park SA, Lee SH, et al. Transplantation of a 3D-printed tracheal graft combined with iPS cell-derived MSCs and chondrocytes. Sci Rep. 2020;10:1–14.
   PubMed Web of Science ®Google Scholar
• Chang M, Bogacheva MS, Lou YR. Challenges for the applications of human pluripotent stem cell-derived liver organoids. Front Cell Dev Biol. 2021;9:1–17.
   Web of Science ®Google Scholar
• Hansel MC, Davila JC, Vosough M, et al. The use of induced pluripotent stem cells for the study and treatment of liver diseases. Curr Protoc Toxicol. 2016;67:1–27.
   Google Scholar
• Liu G, David BT, Trawczynski M, et al. Advances in pluripotent stem cells : history, mechanisms, technologies, and applications. Stem Cell Rev Rep. 2020;16:3–32.
   PubMed Web of Science ®Google Scholar
• Vosough M, Omidinia E, Kadivar M, et al. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev. 2013;22:2693–2705.
   PubMed Web of Science ®Google Scholar
• Xie Y, Yao J, Jin W, et al. Induction and maturation of hepatocyte-like cells in vitro: focus on technological advances and challenges. Front Cell Dev Biol. 2021;9:1–18.
   Web of Science ®Google Scholar
• Wei H, Tan G, Manasi, et al. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res. 2012;9(2):87–100.
   PubMed Web of Science ®Google Scholar
• Sun YQ, Deng MX, He J, et al. Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells. 2012;30:2692–2699.
   PubMed Web of Science ®Google Scholar
• Chow L, Johnson V, Regan D, et al. Peter Koch and SD. Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells. Stem Cell Res. 2017;25:221–232.
   PubMed Web of Science ®Google Scholar
• Feizi Z, Zahmatkesh E, Farzaneh Z, et al. Prenatal liver stromal cells : favorable feeder cells for long ‐ term culture of hepatic progenitor cells. J Cell Biochem. 2019;120:16624–16633.
   PubMed Web of Science ®Google Scholar
• Xu Q. Human three-dimensional hepatic models: cell type variety and corresponding applications. Front Bioeng Biotechnol. 2021;9:1–21.
   Web of Science ®Google Scholar
• Li H, Yang Y, Hong W, et al. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct Target Ther. 2020;5:5.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li Z. CRISPR-Cas systems: overview, innovations and applications in human disease research and gene therapy. Comput Struct Biotechnol J. 2020;18:2401–2415.
   PubMed Web of Science ®Google Scholar
• Kwon D, Ahn HJ, Han MJ, et al. Human Leukocyte antigen class i pseudo-homozygous mesenchymal stem cells derived from human induced pluripotent stem cells. Stem Cell Rev Rep. 2020;16:792–808.
   PubMed Web of Science ®Google Scholar
• Omer L, Hudson EA, Zheng S, et al. CRISPR correction of a homozygous low-density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells. Hepatol Commun. 2017;1:886–898.
   PubMed Web of Science ®Google Scholar
• Lee PC, Truong B, Vega-Crespo A, et al. Restoring ureagenesis in hepatocytes by CRISPR/Cas9-mediated genomic addition to arginase-deficient induced pluripotent stem cells. Mol Ther Nucleic Acids. 2016;5:e394.
   PubMedGoogle Scholar
• Bruno S, Herrera Sanchez MB, Pasquino C, et al. Human liver-derived stem cells improve fibrosis and inflammation associated with nonalcoholic steatohepatitis. Stem Cells Int. 2019;2019:6351091.
   PubMed Web of Science ®Google Scholar
• Bruno S, Pasquino C, Herrera Sanchez MB, et al. HLSC-derived extracellular vesicles attenuate liver fibrosis and inflammation in a murine model of non-alcoholic steatohepatitis. Mol Ther. 2020;28:479–489.
   PubMed Web of Science ®Google Scholar
• Famulari ES, Navarro-Tableros V, Herrera Sanchez MB, et al. Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice. Sci Rep. 2020;10:1–14.
   PubMed Web of Science ®Google Scholar
• Smets F, Dobbelaere D, McKiernan P, et al. Phase I/II Trial of liver–derived mesenchymal stem cells in pediatric liver–based metabolic disorders: a prospective, open label, multicenter, partially randomized, safety study of one cycle of heterologous human adult liver–derived progenitor cells (hepa. Transplantation. 2019;103:1903–1915.
   PubMed Web of Science ®Google Scholar
• Spada M, Porta F, Righi D, et al. Intrahepatic administration of human liver stem cells in infants with inherited neonatal-onset hyperammonemia: a phase i study. Stem Cell Rev Rep. 2020;16:186–197.
   PubMed Web of Science ®Google Scholar
• Zhang L, Pu K, Liu X, et al. The application of induced pluripotent stem cells against liver diseases: an update and a review. Front Med. 2021;8:1–14.
   Web of Science ®Google Scholar
• Ezquer F, Huang YL, Ezquer M. New perspectives to improve mesenchymal stem cell therapies for drug-induced liver injury. Int J Mol Sci. 2022;24:23.
   PubMedGoogle Scholar
• Tang X-Y, Wu S, Wang D, et al. Human organoids in basic research and clinical applications. Signal Transduct Target Ther. 2022;7:7.
   PubMed Web of Science ®Google Scholar
• Ding Y, Xu D, Feng G, et al. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and −9. Diabetes. 2009;58:1797–1806.
   PubMed Web of Science ®Google Scholar
• Ding Y, Bushell A, Wood KJ. Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation. Transplantation. 2010;89:270–273.
   PubMed Web of Science ®Google Scholar
• Zahmatkesh E, Khoshdel-Rad N, Mirzaei H, et al. Evolution of organoid technology: lessons learnt in Co-Culture systems from developmental biology. Dev Biol. 2021;21:0012–0056.
   Google Scholar
• Takebe T, Zhang R, Koike H, et al. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc. 2014;9:396–409.
   PubMed Web of Science ®Google Scholar
• Zahmatkesh E, Ghanian MH, Zarkesh I, et al. Tissue-specific microparticles improve organoid microenvironment for efficient maturation of pluripotent stem-cell-derived hepatocytes. Cells. 2021;10:1274.
   PubMed Web of Science ®Google Scholar
• Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21:571–584.
   PubMed Web of Science ®Google Scholar
• Jitraruch S, Dhawan A, Hughes RD, et al. Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure. PLoS One. 2014;9:1–23.
   Web of Science ®Google Scholar
• Machaidze Z, Yeh H, Wei L, et al. Testing of microencapsulated porcine hepatocytes in a new model of fulminant liver failure in baboons. Xenotransplantation. 2017;(3):24.
   Web of Science ®Google Scholar
• Jitraruch S, Dhawan A, Hughes RD, et al. Cryopreservation of hepatocyte microbeads for clinical transplantation. Cell Transplant. 2017;26:1341–1354.
   PubMed Web of Science ®Google Scholar
• Seng S, Saeb-parsy K, Blackford SJI, et al. Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold. Biomaterials. 2018;182:299–311.
   PubMed Web of Science ®Google Scholar
• Tysoe OC, Justin AW, Brevini T, et al. Isolation and propagation of primary human cholangiocyte organoids for the generation of bioengineered biliary tissue. Nat Protoc. 2019 Springer US;14:1884–1925.
   PubMed Web of Science ®Google Scholar
• Mobarra N, Soleimani M, Ghayour-Mobarhan M, et al. Hybrid poly-l-lactic acid/poly(ε-caprolactone) nanofibrous scaffold can improve biochemical and molecular markers of human induced pluripotent stem cell-derived hepatocyte-like cells. J Cell Physiol. 2019;234:11247–11255.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen X, Hong H, et al. Decellularized extracellular matrix scaffolds: recent trends and emerging strategies in tissue engineering. Bioact Mater. 2022;10:15–31.
   PubMed Web of Science ®Google Scholar
• McCrary MW, Bousalis D, Mobini S, et al. Decellularized tissues as platforms for in vitro modeling of healthy and diseased tissues. Acta Biomater. 2020 Elsevier Ltd;111:1–19.
   PubMed Web of Science ®Google Scholar
• Croce S, Peloso A, Zoro T, et al. A hepatic scaffold from decellularized liver tissue: food for thought. Biomolecules. 2019;9:1–25.
   Web of Science ®Google Scholar
• Damania A, Kumar A, Teotia AK, et al. Decellularized liver matrix-modified cryogel scaffolds as potential hepatocyte carriers in bioartificial liver support systems and implantable liver constructs. ACS Appl Mater Interfaces. 2018;10:114–126.
   PubMed Web of Science ®Google Scholar
• Asadi M, Lotfi H, Salehi R, et al. Hepatic cell-sheet fabrication of differentiated mesenchymal stem cells using decellularized extracellular matrix and thermoresponsive polymer. Biomed Pharmacother. 2021;134:111096.
   PubMed Web of Science ®Google Scholar
• Hussein KH, Park KM, Yu L, et al. Decellularized hepatic extracellular matrix hydrogel attenuates hepatic stellate cell activation and liver fibrosis. Mater Sci Eng C. 2020;116:111160.
   PubMed Web of Science ®Google Scholar
• Hernández A, Arab JP, Reyes D, et al. Extracellular vesicles in NAFLD/ALD: from pathobiology to therapy. Cells. 2020;9:1–14.
   Web of Science ®Google Scholar
• Hassanzadeh A, Rahman HS, Markov A, et al. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther. 2021;12:1–22.
   PubMed Web of Science ®Google Scholar
• Cai J, Wu J, Wang J, et al. Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential. Cell Biosci. 2020;10:1–14.
   PubMed Web of Science ®Google Scholar
• Tingö L, Ahlberg E, Johansson L, et al. Non-coding RNAs in human breast milk: a systematic review. Front Immunol. 2021;12:1–31.
   Web of Science ®Google Scholar
• Kwok ZH, Ni K, Jin Y. Extracellular vesicle associated non-coding RNAs in lung infections and injury. Cells. 2021;10:965.
   PubMed Web of Science ®Google Scholar
• Qu Y, Zhang Q, Cai X, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21:2491–2502.
   PubMed Web of Science ®Google Scholar
• Povero D, Pinatel EM, Leszczynska A, et al. Human induced pluripotent stem cell–derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis. JCI Insight. 2019;4:1–17.
   Web of Science ®Google Scholar
• Herrera MB, Fonsato V, Gatti S, et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med. 2010;14:1605–1618.
   PubMed Web of Science ®Google Scholar
• Tan CY, Lai RC, Wong W, et al. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther. 2014;5:1–14.
   Web of Science ®Google Scholar
• Yan Y, Jiang W, Tan Y, et al. hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury. Mol Ther. 2017;25:465–479.
   PubMed Web of Science ®Google Scholar
• Jiang W, Tan Y, Cai M, et al. Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect. Stem Cells Int. 2018;2018:6079642.
   PubMed Web of Science ®Google Scholar
• Haga H, Yan IK, Borrelli DA, et al. Extracellular vesicles from bone marrow–derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury. Liver Transplant. 2017;23:791–803.
   PubMed Web of Science ®Google Scholar
• Nong K, Wang W, Niu X, et al. Hepatoprotective effect of exosomes from human-induced pluripotent stem cell–derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats. Cytotherapy. 2016;18:1548–1559.
   PubMed Web of Science ®Google Scholar
• Du Y, Li D, Han C, et al. Exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect liver against hepatic ischemia/ reperfusion injury via activating sphingosine kinase and sphingosine-1-phosphate signaling pathway. Cell Physiol Biochem. 2017;43:611–625.
   PubMedGoogle Scholar
• Yao J, Zheng J, Cai J, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. FASEB J. 2019;33:1695–1710.
   PubMed Web of Science ®Google Scholar
• Anger F, Camara M, Ellinger E, et al. Human mesenchymal stromal cell-derived extracellular vesicles improve liver regeneration after ischemia reperfusion injury in mice. Stem Cells Dev. 2019;28:1451–1462.
   PubMed Web of Science ®Google Scholar
• Haga H, Yan IK, Takahashi K, et al. Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice. Stem Cells Transl Med. 2017;6:1262–1272.
   PubMed Web of Science ®Google Scholar
• Chen L, Xiang B, Wang X, et al. Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure. Stem Cell Res Ther. 2017;8:1–15.
   PubMed Web of Science ®Google Scholar
• Jin Y, Wang J, Li H, et al. Extracellular vesicles secreted by human adipose-derived stem cells (hASCs) improve survival rate of rats with acute liver failure by releasing lncRNA H19. EBioMedicine. 2018;34:231–242.
   PubMed Web of Science ®Google Scholar
• Tamura R, Uemoto S, Tabata Y. Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model. Inflamm Regen. 2016;36:1–11.
   PubMed Web of Science ®Google Scholar
• Damania A, Jaiman D, Teotia AK, et al. Mesenchymal stromal cell-derived exosome-rich fractionated secretome confers a hepatoprotective effect in liver injury. Stem Cell Res Ther. 2018;9:1–12.
   PubMed Web of Science ®Google Scholar
• Nojima H, Freeman CM, Schuster RM, et al. Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. J Hepatol. 2016;64:60–68.
   PubMed Web of Science ®Google Scholar